Cwm, LLC Atara Biotherapeutics, Inc. Transaction History

Cwm, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$0.39 - $8.88 $7,567 - $172,307	-19,404 Reduced 97.28%	542 $5,000
Q1 2024 Apr 05, 2024	BUY	$0.44 - $1.22 $2,720 - $7,544	6,184 Added 44.94%	19,946 $14,000
Q4 2023 Feb 01, 2024	BUY	$0.23 - $1.74 $3,000 - $22,701	13,047 Added 1824.76%	13,762 $7,000
Q3 2023 Oct 11, 2023	BUY	$1.41 - $2.31 $820 - $1,344	582 Added 437.59%	715 $1,000
Q1 2023 Apr 28, 2023	SELL	$2.8 - $5.46 $1,562 - $3,046	-558 Reduced 80.75%	133 $0
Q4 2022 Feb 01, 2023	SELL	$2.85 - $5.18 $1,137 - $2,066	-399 Reduced 36.61%	691 $2,000
Q3 2022 Oct 27, 2022	BUY	$2.85 - $8.73 $3,106 - $9,515	1,090 New	1,090 $4,000
Q2 2022 Jul 28, 2022	SELL	$4.69 - $9.84 $520 - $1,092	-111 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$8.44 - $16.89 $936 - $1,874	111 New	111 $1,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.15B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.